Although not within the PVN, a handful of previous reports showed that systemic injection of anti-TLR4 antibody decreases serum levels of IL-6 in SHR [3] and systemically infused TLR4 antagonist reduces serum levels of inflammatory markers in heart failure animals [51]. This evidence concerns the gene IL6 and heart failure.